Company intelligence / Profile preview

CHA Meditech

South Koreachamt.co.kr ↗
Ownership
Private
Development stage
Commercial
01

Overview

CHA Meditech has commercialized its hyaluronic acid filler "HyaFilia" with regulatory approval and sales in China and other global markets. The company also develops novel synthetic pulmonary surfactants with promising preclinical results comparable to established therapies like Curosurf®. Its R&D covers both medical device/aesthetic products and therapeutic biomaterials.

Therapeutic areas
PulmonologyDermatologyMen's Health
Modalities
Recombinant protein (e.g., synthetic surfactant peptides)Peptides (growth factors, peptide-based products)Small molecule (cosmetic ingredients/natural extracts)Device (medical devices for aesthetics)
Industry
Biotech
02

Drug pipeline

2 assets

HYAFILIA

Commercial
Indications
Aesthetic medicine

1 more asset in the full pipeline.

Request access →
03

Partnerships

supply contract with Chinese aesthetic/plastic surgery device distributorlocal/global distributors in China/Brazil/Thailand

Beyond the preview

Go deeper on CHA Meditech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CHA Meditech.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call